Aurinia Pharmaceuticals — Acquisitions & M&A Deals

1 deal

Tracking 1 M&A deal by Aurinia Pharmaceuticals.

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Business Wire

HealthcareMerger

Aurinia Pharmaceuticals→Kezar Life Sciences

Mar 30, 2026